Table 6.
Comparison of FA composition and cheek cell correlation of the present study with relevant literature
| |
Cheek cell FA composition |
Cheek cell FA correlation |
||||||
|---|---|---|---|---|---|---|---|---|
| Reference | Connor et al. (2000)[20] | Staps and Kuhnt (2010)[unpublished] | Klingler et al. (2013)[11] | Present study | Klingler et al. (2013)[11] | Present study | ||
| Study group |
Control group |
Total subjects; baseline values |
Total subjects; baseline values |
Total subjects; baseline values |
Total subjects; baseline values |
Total subjects; baseline values |
||
| Subjects |
Infants |
Adults |
Adults |
Adults |
Adults |
Adults |
||
| (n = 8) |
(n = 4) |
(n = 13) |
(n = 38) |
(n = 13) |
(n = 38) |
|||
| Lipid class |
Phospholipids |
Total lipids |
Glycerophospholipids |
Total lipids |
Glycerophospholipids |
Total lipids |
||
| |
% FAME |
% FAME |
mol% |
% FAME |
r
1
Plasma |
r
1
RBC |
r
1
Plasma |
r
1
RBC |
|
SFA |
|
|
|
|
|
|
|
|
| C16:0 |
14.5 |
15.6 |
16.6 |
17.1 |
0.64* |
0.32 |
-0.08 |
-0.10 |
| C18:0 |
12.3 |
11.4 |
15.3 |
16.5 |
0.70** |
0.33 |
0.04 |
-0.16 |
|
n-9 MUFA |
|
|
|
|
|
|
|
|
| C18:1n-9 (OA) |
25.8 |
28.9 |
30.1 |
26.7 |
0.40 |
0.10 |
0.34* |
0.06 |
|
n-6 PUFA |
|
|
|
|
|
|
|
|
| C18:2n-6 (LA) |
16.5 |
18.4 |
17.3 |
17.1 |
-0.04 |
-0.05 |
-0.59 |
0.21 |
| C20:4n-6 (AA) |
2.00 |
4.37 |
3.20 |
3.32 |
0.65** |
0.17 |
0.54*** |
0.54*** |
| C22:5n-6 |
1.00 |
0.12 |
0.07 |
0.06 |
0.78*** |
0.70** |
0.52*** |
0.58*** |
|
n-3 PUFA |
|
|
|
|
|
|
|
|
| C18:3n-3 (ALA) |
0.40 |
0.23 |
0.24 |
0.29 |
0.11 |
0.13 |
0.17 |
0.06 |
| C20:5n-3 (EPA) |
0.10 |
0.55 |
0.21 |
0.22 |
0.66 |
0.79** |
0.81*** |
0.82*** |
| C22:5n-3 (DPA) |
0.20 |
0.43 |
0.23 |
0.22 |
0.85 |
0.39 |
0.73*** |
0.67*** |
| C22:6n-3 (DHA) | 0.40 | 1.07 | 0.69 | 0.79 | 0.76*** | 0.88*** | 0.68*** | 0.64*** |
1r Pearson's correlation coefficient; *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001.